
    
      This is a single-center, single-arm, prospective, pilot study to evaluate the effectiveness
      and safety of B/F/TAF in viremic HIV-1 infected treatment naive or experienced patients with
      active illicit substance use outside of nicotine, alcohol, and marijuana use.
    
  